At a glance
- Originator Bridge BioResearch
- Class Antihyperglycaemics; Diterpenes
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 14 Aug 2015 Discontinued - Phase-II for Type-2 diabetes mellitus in Denmark (PO)
- 13 Jan 2012 Phase-II clinical trials in Type-2 diabetes mellitus in Denmark (PO)